✦ LIBER ✦

Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

✍ Scribed by R. Wenham; J. LaPolla; L. Hui-Yi; S. Apte; W. Roberts; J. Lancaster; J. Gonzalez Bosquet; S. Theodore; L. Havrilesky; A. Alvarez-Secord

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of docetaxel and bevaci

✍ Wenham, Robert M.; Lapolla, James; Lin, Hui-Yi; Apte, Sachin M.; Lancaster, John 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Phase II trial of docetaxel and carbopla

✍ H.G. Strauss; A. Henze; A. Teichmann; I. Karbe; A. Baumgart; C. Thomssen; H. Koe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Phase I trial of a formulated IL-12 plas

✍ Anwer, Khursheed; Kelly, F. Joseph; Chu, Christina; Fewell, Jason G.; Lewis, Dan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Phase I/II trial of docetaxel and vinore

✍ Leu, Kirsten M; Kim, KyungMann; Larson, Marilyn; Larson, Martha; Schiller, Joan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A phase II clinical trial of pegylated l

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Corrigendum to: “Phase I trial of a form

✍ Anwer, Khursheed; Kelly, F. Joseph; Chu, Christina; Fewell, Jason G.; Lewis, Dan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12&#xa0;months of prior platinum-based chemotherapy